Nasal spray vaccine aims to protect kids from RSV
NCT ID NCT05655182
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tests a new nasal spray vaccine (BLB-201) for RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to see if the vaccine is safe and helps the body build defenses against RSV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR Newton
RECRUITINGNewton, Kansas, 67114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Clinical Research Prime
RECRUITINGRexburg, Idaho, 83440, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Paradigm Clinical Research
RECRUITINGLa Mesa, California, 91942, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Paradigm Clinical Research - Modesto
RECRUITINGModesto, California, 95355, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research - Lafayette
RECRUITINGLafayette, Louisiana, 70508, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research, Austin
RECRUITINGCedar Park, Texas, 78613, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Velocity Clinical Research, Boise
RECRUITINGMeridian, Idaho, 83642, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research, Cleveland
RECRUITINGBeachwood, Ohio, 44122, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research, Grand Island
RECRUITINGGrand Island, Nebraska, 68803, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.